Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
11.52
+0.37 (3.32%)
At close: Feb 27, 2026, 4:00 PM EST
11.52
0.00 (0.00%)
After-hours: Feb 27, 2026, 7:00 PM EST
Biohaven Market Cap
Biohaven has a market cap or net worth of $1.53 billion as of February 27, 2026. Its market cap has decreased by -64.46% in one year.
Market Cap
1.53B
Enterprise Value
1.57B
1-Year Change
-64.46%
Ranking
Category
Stock Price
$11.52
Market Cap Chart
Since September 23, 2022, Biohaven's market cap has increased from $261.58M to $1.53B, an increase of 484.37%. That is a compound annual growth rate of 67.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 1.48B | -1.24% |
| Dec 31, 2025 | 1.50B | -60.34% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 261.68% |
| Sep 23, 2022 | 261.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnaptysBio | 1.55B |
| Tango Therapeutics | 1.54B |
| Corvus Pharmaceuticals | 1.53B |
| EyePoint | 1.48B |
| Trevi Therapeutics | 1.48B |
| Savara | 1.48B |
| Monte Rosa Therapeutics | 1.47B |
| Vir Biotechnology | 1.46B |